Diclofenac Phonophoresis Versus High Power Pain Threshold Ultrasound on Patients With Neck Pain

NCT05434039 | Unknown

• 1 other identifier: p.t.REC/012/003672
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

the aim of this study is to investigate the effect of diclofenac phonophoresis versus high power pain threshold ultrasound in patients with mechanical non-specific neck pain

Conditions

Neck Pain

Keywords

phonophoresis; high power pain threshold ultrasound; neck pain

Outcome Measures

Primary Outcomes (1)

• pain intensity

  The scale that will be used is visual analogue scale ;each subject will be instructed to put point on line from no pain to tolerable pain

  up to four weeks

Secondary Outcomes (3)

• cervical range of motion

  up to four weeks

• pressure pain threshold

  up to four weeks

• neck disability

  up to four weeks

Study Arms (3)

diclofenac phonophoresis

EXPERIMENTAL

the patients will receive diclofenac phonophoresis and traditional therapy three times a week for four weeks

Other: diclofenac phonophoresis; Other: conventional therapy

high power pain threshold ultrasound

EXPERIMENTAL

the patients will receive high power pain threshold ultrasound and traditional therapy three times a week for four weeks

Other: high power pain threshold ultrasound; Other: conventional therapy

conventional therapy

ACTIVE COMPARATOR

the patients will receive traditional therapy three times a week for four weeks

Other: conventional therapy

Interventions

diclofenac phonophoresis OTHER

the patients will be in comfortable position and apply diclofenac phonophoresis on upper trapezius and suboccipital muscle by ultrasound device. diclofenac gel was applied circularly with a thickness of 2-3 mm. Then ultrasound with was applied with 1 MHz frequency and 1.5 Wt/cm2 power over the trigger points on the trapezius and suboccipital muscle, for 10 min.

diclofenac phonophoresis

high power pain threshold ultrasound OTHER

the patients will be in comfortable position and The frequency was set to 1 MHz, and the intensity will be increased from 0.5 to 2 until the patient reported an unpleasant sensation. The probe was held there for 4 s; then, the intensity was reduced by 50%, and the probe will be moved over and around the trigger point. This process is done several times for three minutes

high power pain threshold ultrasound

conventional therapy OTHER

the patient will receive an active range of motion exercise, stretching and strengthening of all cervical muscles

conventional therapy; diclofenac phonophoresis; high power pain threshold ultrasound

Eligibility Criteria

• Age: 18 Years - 30 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• diagnosed as non-specific neck pain with upper trapezius and suboccipital muscles active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
• body mass index from 18 to 25 kg/m2
• their ages from 18-30

You may not qualify if:

• if they had trigger point injections within the past 6 months
• history of neck or upper back surgery, trauma or fracture
• history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
• cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Sponsors & Collaborators

• Cairo University: lead

MeSH Terms

Conditions

Neck Pain

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

al shaymaa sh abd el azeim, lecturer

CONTACT

01033771553; shimaashaaban30@yahoo.com

al shaymaa abd el azeim, lecturer

CONTACT

01033771553; shimaashaaban30@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Masking Details: random generator
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principle investigator

Model Details: diclofenac phonophoresis and high power pain threshold

Study Record Dates

• First Submitted: June 22, 2022
• First Posted: June 27, 2022
• Study Start: July 30, 2022
• Primary Completion: September 1, 2022
• Study Completion: September 1, 2022
• Last Updated: July 27, 2022

Record last verified: 2022-07